Stage IVA Squamous Cell Carcinoma of the Larynx
| Drug | Drug Name | Drug Description |
|---|
| Drug | Drug Name | Target | Type |
|---|
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB00002 | Cetuximab | 1 | Completed | 1 |
| DB00515 | Cisplatin | 1 | Completed | 1 |
| DB00515 | Cisplatin | 1 | Withdrawn | 1 |
| DB01248 | Docetaxel | 1 | Completed | 2 |
| DB00530 | Erlotinib | 1 | Completed | 1 |
| DB12117 | Mitometh | 1 | Completed | 1 |
| DB12117 | Mitometh | 1 | Withdrawn | 1 |
| DB12303 | Motolimod | 1 | Completed | 1 |
| DB00398 | Sorafenib | 1 | Completed | 1 |
| DB00002 | Cetuximab | 1 / 2 | Active Not Recruiting | 1 |
| DB00530 | Erlotinib | 1 / 2 | Completed | 1 |
| DB08916 | Afatinib | 2 | Active Not Recruiting | 1 |
| DB00958 | Carboplatin | 2 | Completed | 1 |
| DB00002 | Cetuximab | 2 | Completed | 1 |
| DB01254 | Dasatinib | 2 | Completed | 1 |
| DB04845 | Ixabepilone | 2 | Completed | 1 |
| DB01259 | Lapatinib | 2 | Completed | 1 |
| DB01229 | Paclitaxel | 2 | Completed | 1 |
| DB11805 | Saracatinib | 2 | Completed | 1 |
| DB00398 | Sorafenib | 2 | Completed | 2 |
| DB00002 | Cetuximab | 2 / 3 | Active Not Recruiting | 1 |
| DB00515 | Cisplatin | 2 / 3 | Active Not Recruiting | 1 |
| DB01248 | Docetaxel | 2 / 3 | Active Not Recruiting | 1 |
| DB12117 | Mitometh | 2 / 3 | Active Not Recruiting | 1 |
| DB06151 | Acetylcysteine | Not Available | Active Not Recruiting | 1 |
| DB00002 | Cetuximab | Not Available | Suspended | 1 |
| DB00515 | Cisplatin | Not Available | Suspended | 1 |
| DB00317 | Gefitinib | Not Available | Completed | 1 |
| DB12117 | Mitometh | Not Available | Suspended | 1 |